Z-drugs

Drowsiness, poor coordination, impaired memory and next-day impairment can occur. Zopiclone product information describes complex sleep behaviours, including activities undertaken while not fully awake, sometimes without later recall. Respiratory depression is a concern, especially with other depressants.

Repeated use can produce tolerance and reliance on the medicine, while persistent insomnia still requires assessment of its underlying causes. Falls and cognitive impairment are relevant when sedation continues, particularly in older people. These risks do not mean everyone prescribed a short course becomes addicted.

Physical dependence can develop during prescribed use. Stopping suddenly can cause rebound insomnia, anxiety and agitation; severe withdrawal may include hallucinations or, rarely, seizures. Agree a gradual, individual reduction plan with the prescriber and adjust it to symptoms. Withdrawal symptoms are not automatically evidence that the original sleep problem has returned.

Alcohol, opioids, benzodiazepines, gabapentinoids and other sedatives increase impairment and can worsen breathing suppression. Some medicines alter zopiclone concentrations. A pharmacist or prescriber should review the full combination rather than relying on the label Z-drug.